ULTRAGENYX UK LIMITED
Company number 09479213 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2015-03-09
- Registered office
- Suite 1, 7th Floor 50 Broadway, London, United Kingdom, SW1H 0BL
- Postcode
- SW1H 0BL
- Capital
- 1 GBP
- Accounts category
- Small
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-03-09
- Next due by
- 2027-03-23
Nature of business (SIC)
- 74990 Non-trading company
Officers 4 current · 3 resigned
Andrea BAZZOTTI
Director
David Joseph NESTOR
Director
Jane Elizabeth COOPER
Director
VISTRA COMPANY SECRETARIES LIMITED
Corporate Secretary · corporate
Group structure
Controlled by Ultragenyx Pharmaceutical Inc. (RARE) — since 2016-07-11
From persons-with-significant-control filings on the public register.
Contact details
- Website
- ultragenyx.uk
Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Previous registered addresses 1
| Address | Changed on |
|---|---|
| 20-22 BEDFORD ROW LONDON, WC1R 4JS, UNITED KINGDOM | 2017-06-26 |
The class of 2015
23%
of the 4,867 companies in this sector incorporated in 2015 are still active today; 75% have since been dissolved.
A fact about the year, not a forecast for this company.